Catalyst Wire Dossier Catalyst Wire Dossier

CD19-targeting CAR-T therapy

CAR-T cell therapy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19-targeting CAR-T therapy, covering 2025-07-17 to 2025-07-17. Get the full timeline:

Most recent: Clinical Trial Update: Mitoxantrone Hydrochloride Liposome Injection-containing Bridging Regimen and CD19-targeting CAR-T Therapies [Phase 2]

See pricing